Device type · EOX
Esophagoscope (Flexible Or Rigid)
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
EOX
Ear, Nose & Throat
Device class
Class II
FDA decisions since 2015
12
510(k), De Novo and PMA
Adverse event reports
1
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Esophagoscope (Flexible Or Rigid)
- Product code
- EOX
- Device class
- Class II
- Review panel
- Ear, Nose & Throat
- Regulation
- 21 CFR 874.4710
- Specialty
- Otolaryngology (ENT)
- FDA record
- Classification database entry for EOX
Latest FDA decisions
The 8 newest of 12 since 2015.
K233142 · Decided Jan 19, 2024 · 114 days after receipt
Device type: Esophagoscope (Flexible Or Rigid) (EOX) · Otolaryngology (ENT)
K230339 · Decided Feb 24, 2023 · 17 days after receipt
Device type: Esophagoscope (Flexible Or Rigid) (EOX) · Otolaryngology (ENT)
K223072 · Decided Dec 2, 2022 · 63 days after receipt
Device type: Esophagoscope (Flexible Or Rigid) (EOX) · Otolaryngology (ENT)
9 more FDA decisions with a free account
Reports received
1
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
1
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 2 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 1 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Fluid/Blood Leak1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1899-2024 · Started Apr 24, 2024 · Posted by FDA May 24, 2024
Reason given: The EsophaCap sponge may be at increased risk of detaching from the string during removal of the device from the patient, particularly at the lower esophageal sphincter at the gastroesophageal junction or the upper esophageal sphincter between the pharynx and the esophagus, which is the narrowest part of the...
Cause as FDA categorized it: Under Investigation by firm
Z-1900-2024 · Started Apr 24, 2024 · Posted by FDA May 24, 2024
Reason given: The EsophaCap sponge may be at increased risk of detaching from the string during removal of the device from the patient, particularly at the lower esophageal sphincter at the gastroesophageal junction or the upper esophageal sphincter between the pharynx and the esophagus, which is the narrowest part of the...
Cause as FDA categorized it: Under Investigation by firm
- Covidien Cytosponge Cell Collection Device, REF: CYTO-201; and Covidien Cytosponge Cell Collection Kit, REF: CYTO-KIT-USMOpen, Classified
Z-2282-2023 · Started Jun 2, 2023 · Posted by FDA Aug 2, 2023
Reason given: Cell Collection Device may be at increased risk of the sponge detaching from the string during removal of the device from the patient, which could lead to device fragments in patient, obstruction, airway obstruction, secondary intervention, secondary intervention (with the primary procedure), supraglottic airway...
Cause as FDA categorized it: Process control
5 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.